Annual General Meeting Scheduled for December 11, 2020
OTTAWA, Dec. 04, 2020 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release its financial results for the fiscal first quarter 2021, before market hours on December 14, 2020, as well as host a webcast for investors beginning at 8:30 a.m. EST.
Webcast Details
Date: December 14, 2020
Time: 8:30 a.m. EST
Webcast: https://event.on24.com/wcc/r/2876521/3E600F67F53F73D721304EA073134431
Shareholders of the Company are reminded that the Company will be holding an annual and special meeting of shareholders (the “Meeting”) scheduled on December 11, 2020. Proxies must be deposited with the Company’s transfer agent and registrar, TSX Trust Company, not later than 10:00 a.m. (EST) on Wednesday, December 9, 2020. For additional information on the Meeting, the Meeting material can be accessed online under the Company’s profile on SEDAR at www.sedar.com, EDGAR at www.sec.gov or at https://docs.tsxtrust.com/2092, the website for the Meeting materials maintained by TSX Trust Company.
For previous quarterly results and recent press releases, see hexocorp.com.
About HEXO Corp
HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.
Investor Relations:
invest@HEXO.com
Media Relations:
(819) 317-0526
media@hexo.com
Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…
Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE…
Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…
PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…